Ironwood Pharma (IRWD) Misses Q1 EPS by 4c

Ironwood Pharma (NASDAQ: IRWD) reported Q1 EPS of $0.21, $0.04 worse than the analyst estimate of $0.25. Revenue for the quarter came in at $98 million versus the consensus estimate of $93.97 million.

GUIDANCE:

Ironwood Pharma sees FY2022 revenue of $420-430 million, versus the consensus of $430 million.

For earnings history and earnings-related data on Ironwood Pharma (IRWD) click here.

You May Also Be Interested In

• HealthEquity (HQY) Tops Q2 EPS by 5c ; Offers Guidance
• Dollar General (DG) Tops Q2 EPS by 48c, Beats on Revenue; Offers FY27 EPS Guidance
• Hormel Foods (HRL) Tops Q3 EPS by 2c, Misses on Revenue; Offers FY26 Guidance